Report overview
Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
This report aims to provide a comprehensive presentation of the global market for Enzyme Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme Replacement Therapy. This report contains market size and forecasts of Enzyme Replacement Therapy in global, including the following market information:
Global Enzyme Replacement Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enzyme Replacement Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Enzyme Replacement Therapy companies in 2022 (%)
The global Enzyme Replacement Therapy market was valued at US$ 12170 million in 2022 and is projected to reach US$ 29350 million by 2029, at a CAGR of 13.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.
In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.
We surveyed the Enzyme Replacement Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enzyme Replacement Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enzyme Replacement Therapy Market Segment Percentages, by Type, 2022 (%)
Injectable Agents
Oral Agents
Global Enzyme Replacement Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enzyme Replacement Therapy Market Segment Percentages, by Application, 2022 (%)
Gaucher Disease
Fabry Disease
MPS Disease
Gastrointestinal Disease
Others
Global Enzyme Replacement Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enzyme Replacement Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enzyme Replacement Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enzyme Replacement Therapy revenues share in global market, 2022 (%)
Key companies Enzyme Replacement Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Enzyme Replacement Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enzyme Replacement Therapy, market overview.
Chapter 2: Global Enzyme Replacement Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Enzyme Replacement Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enzyme Replacement Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enzyme Replacement Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
